Totals
- Total revenue
- $2,206,690
- Total expenses
- $1,297,473
- Contributions and grants received
- $2,067,538
- Grants paid
- $812,441
- Program service revenue
- $0
- Investment income
- $106,759
- Other revenue
- $32,393
- Total assets, end of year
- $4,575,765
- Total liabilities, end of year
- $1,332,126
- Net assets or fund balances, end of year
- $3,243,639
- Program services expenses (Part IX)
- $1,147,898
- Management and general expenses
- $107,005
- Fundraising expenses
- $42,570
- Program service expenses (Part III)
- $1,147,898
Program services were 88.5% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$2,067,538
-
3 · Investment income
total $106,218 · excluded $106,218
-
7a · Gross sales of assets other than inventory
securities $62,059
-
7b · Less cost or other basis and sales expenses
securities $61,518
-
7c · Gain or loss
securities $541
-
7d · Net gain or loss
total $541 · excluded $541
-
8a · Fundraising events: gross income
$51,612
-
8b · Fundraising events: direct expenses
$19,219
-
8c · Net income from fundraising events
total $32,393 · excluded $32,393
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $662,461 · program services $662,461
-
2 · Grants to domestic individuals
total $0
-
3 · Grants to foreign organizations and individuals
total $149,980 · program services $149,980
-
4 · Benefits paid to or for members
total $0
-
5 · Compensation of officers, directors and key employees
total $183,750 · program services $129,506 · management and general $34,553 · fundraising $19,691
-
6 · Compensation of disqualified persons
total $0
-
7 · Other salaries and wages
total $139,786 · program services $98,839 · management and general $26,211 · fundraising $14,736
-
8 · Pension plan contributions
total $0
-
9 · Other employee benefits
total $17,428 · program services $12,636 · management and general $3,311 · fundraising $1,481
-
10 · Payroll taxes
total $22,348 · program services $15,895 · management and general $4,168 · fundraising $2,285
-
11a · Fees: management
total $13,146 · program services $8,022 · management and general $5,124
-
11b · Fees: legal
total $3,187 · program services $2,391 · management and general $637 · fundraising $159
-
11c · Fees: accounting
total $20,413 · program services $15,309 · management and general $4,083 · fundraising $1,021
-
11d · Fees: lobbying
total $0
-
11f · Fees: investment management
total $0
-
11g · Fees: other
total $0
-
12 · Advertising and promotion
total $4,716 · program services $3,078 · management and general $879 · fundraising $759
-
13 · Office expenses
total $0
-
14 · Information technology
total $21,574 · program services $1,637 · management and general $19,777 · fundraising $160
-
15 · Royalties
total $0
-
16 · Occupancy
total $36,450 · program services $27,337 · management and general $7,290 · fundraising $1,823
-
17 · Travel
total $0
-
18 · Travel or entertainment for public officials
total $0
-
19 · Conferences, conventions and meetings
total $3,683 · program services $3,548 · fundraising $135
-
20 · Interest
total $0
-
21 · Payments to affiliates
total $0
-
22 · Depreciation, depletion and amortization
total $2,272 · program services $2,158 · management and general $57 · fundraising $57
-
23 · Insurance
total $3,592 · program services $2,694 · management and general $718 · fundraising $180
-
24a · Other expenses: Program development
total $11,478 · program services $11,478
-
24b · Other expenses: Other
total $1,209 · program services $929 · management and general $197 · fundraising $83
-
24e · All other expenses
total $0
Balance sheet
Part X, book values.
-
2 · Savings and temporary cash investments
beginning of year $2,536,867 · end of year $1,117,346
-
3 · Pledges and grants receivable
beginning of year $125,337 · end of year $433,333
-
9 · Prepaid expenses and deferred charges
beginning of year $3,844 · end of year $1,795
-
10a · Land, buildings and equipment: cost or other basis
$3,139
-
10b · Land, buildings and equipment: accumulated depreciation
$1,570
-
10c · Land, buildings and equipment, net
beginning of year $2,197 · end of year $1,569
-
11 · Investments: publicly traded securities
beginning of year $799,253 · end of year $2,986,306
-
14 · Intangible assets
beginning of year $1,645
-
15 · Other assets
beginning of year $3,009 · end of year $35,416
-
17 · Accounts payable and accrued expenses
beginning of year $20,651 · end of year $23,721
-
18 · Grants payable
beginning of year $1,104,990 · end of year $1,308,405
-
27 · Net assets without donor restrictions
beginning of year $693,470 · end of year $881,895
-
28 · Net assets with donor restrictions
beginning of year $1,653,041 · end of year $2,361,744
Mission and programs · 2022
Mission
Cures Within Reach leverages the speed, safety and cost-effectiveness of testing approved therapies for new indications/diseases without effective treatment driving more treatments to more patients more quickly.
Activities or mission (Part I)
To help patients by raising funds to find, vet, finance and manage pilot human clinical trials that test already approved drugs, devices and other products to deliver fast, safe and affordable treatments for both common
-
Repurposing research In its main area of focus, the organization catalyzes clinical trials testing approved therapies by finding and facilitating these proof-of-concept clinical trials that, when successful, catalyze follow-on funding for further trials and publications in order to allow broad patient use. In FY 2023 14 new or expanded clinical trials were signed in rare diseases, ear nose throat, neurology and oncology 7 trials were completed or closed in oncology, rare diseases, neurology, and ear nose throat and 37 trials were still in progress - for a total of 44 ongoing trials as of 7/31/23.
Expenses $1,147,898 · Grants $812,440
As filed on the 2022 return.
Listed in Part VII
-
Barbara Goodman
President CEO
- Total calculated
- $187,425
- From this org
- $183,750
- From related orgs
- $0
- Other
- $3,675
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $175,000
- Bonus
- $8,750
- Other
- not reported
- Deferred
- not reported
- Nontaxable benefits
- $3,675
- Filer's total
- $187,425
-
Margaret Christie
Chair
- Total calculated
- $0
- Hours/week
- 2
-
Lucy Mancini-Newell
Secretary
- Total calculated
- $0
- Hours/week
- 1
-
Matthew Rich
Treasurer
- Total calculated
- $0
- Hours/week
- 1
-
Kristina Allikmets
Director
- Total calculated
- $0
- Hours/week
- 1
-
Steve Braun
Director
- Total calculated
- $0
- Hours/week
- 1
-
Nick Manusos
Director
- Total calculated
- $0
- Hours/week
- 1
-
Robert Metz
Director
- Total calculated
- $0
- Hours/week
- 1
-
David Styler
Director
- Total calculated
- $0
- Hours/week
- 1
-
Nancy Sullivan
Director
- Total calculated
- $0
- Hours/week
- 1
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Form 990 of other organizations
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$82,000
To support clinical trials/medical research
-
To support clinical trials/medical research
-
University of NC at Chapel Hill
$67,000
To support clinical trials/medical research
-
To support clinical trials/medical research
-
To support clinical trials/medical research
-
$60,000
To support clinical trials/medical research
-
University of Texas MD Anderson Cancer Center
$60,000
To support clinical trials/medical research
-
$60,000
To support clinical trials/medical research
-
$56,000
To support clinical trials/medical research
-
$40,000
To support clinical trials/medical research
The 10 largest by cash amount. The API serves every itemized grant.
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 30 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202313499349300341
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.